MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Skin and Allergy News' source. Tue, 02 Mar 2010 14:15:10 +0100 http://www.medworm.com/index.php?rid=3168835&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633710700310%2Fabstract%3Frss%3Dyes PORTLAND, ORE. — The eruption was marked by sharply demarcated areas of erythema with overlying hyperkeratosis, symmetrically distributed over the trunk and extremities, with involvement of the face. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3168835 Fri, 01 Jan 2010 00:00:00 +0100 3168835 http://www.medworm.com/index.php?rid=3168834&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633710700309%2Fabstract%3Frss%3Dyes Dr. Charlotte Cowan was practicing at Boston's MassGeneral Hospital for Children in 2000 when she approached the chairman of pediatrics about her aspiration to write stories for sick children in an illustrated picture book format. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3168834 Fri, 01 Jan 2010 00:00:00 +0100 3168834 http://www.medworm.com/index.php?rid=3168833&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633710700292%2Fabstract%3Frss%3Dyes Glytone is offering three new antiaging products that will be available exclusively to physicians beginning this month. The day cream, the eye cream, and the facial serum contain high concentrations of time-released antioxidants vitamin C, vitamin E, and red tea extract. The eye cream also contains glycolic acid, caffeine, and licorice extract to reduce puffiness around the eye area. The facial serum and the day cream help reduce visible signs of aging and protect against further environmental and free radical damage. The facial serum and day cream are best if used on normal or oily skin. The three products can be used together or individually. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3168833 Fri, 01 Jan 2010 00:00:00 +0100 3168833 http://www.medworm.com/index.php?rid=3168832&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633710700280%2Fabstract%3Frss%3Dyes BOSTON — Experts have been touting the potential of virtual office visits for years, but the concept may finally be hitting the mainstream now that technology, reimbursement, and patient demand are starting to catch up. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3168832 Fri, 01 Jan 2010 00:00:00 +0100 3168832 http://www.medworm.com/index.php?rid=3168831&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633710700279%2Fabstract%3Frss%3Dyes DR. EASTERN practices dermatology and dermatologic surgery in Belleville, N.J. To respond to this column, e-mail Dr. Eastern at sknews@elsevier.com. A brand new year has begun, and that, as usual, means brand new surprises from our friends at the Centers for Medicare and Medicaid Services. This year's big surprise: The CMS has decided it will no longer pay for consultations in either outpatient (99241-99245) or inpatient (99251-99255) settings. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3168831 Fri, 01 Jan 2010 00:00:00 +0100 3168831 http://www.medworm.com/index.php?rid=3168830&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633710700267%2Fabstract%3Frss%3Dyes The National Cancer Institute and the pharmaceutical maker Allergan Inc. are jointly supporting a trial to determine whether bimatoprost (Latisse) can stimulate regrowth of eyelashes and eyebrows after their loss in chemotherapy. The company told a Food and Drug Administration advisory committee in December 2008 that it would explore that potential use of the drug. The study began enrolling patients in October and will be led by Dr. Jenny Kim of the Jonsson Comprehensive Cancer Center at University of California, Los Angeles. Men and women who have been diagnosed with breast cancer will be enrolled at nine sites and followed for 6 months. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3168830 Fri, 01 Jan 2010 00:00:00 +0100 3168830 http://www.medworm.com/index.php?rid=3168829&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633710700255%2Fabstract%3Frss%3Dyes DR. PICHICHERO, a specialist in pediatric infectious diseases, is director of the Rochester (N.Y.) General Research Institute. With the licensure of GlaxoSmithKline's human papillomavirus vaccine Cervarix in October, we will soon have two vaccines that prevent cervical cancer in women. But they're not interchangeable, and this could lead to problems. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3168829 Fri, 01 Jan 2010 00:00:00 +0100 3168829 http://www.medworm.com/index.php?rid=3168828&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633710700243%2Fabstract%3Frss%3Dyes The human papillomavirus 16/18 vaccine showed efficacy, sustained immunogenicity, and continued safety for up to 6.4 years in a combination of initial and follow-up placebo-controlled studies involving more than 1,000 women aged 15-26 years. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3168828 Fri, 01 Jan 2010 00:00:00 +0100 3168828 http://www.medworm.com/index.php?rid=3168827&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633710700231%2Fabstract%3Frss%3Dyes CHICAGO — Radiation therapy significantly reduced the risk of recurrence in melanoma patients at high risk of relapse after lymphadenectomy, according to a phase III intergroup trial. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3168827 Fri, 01 Jan 2010 00:00:00 +0100 3168827 http://www.medworm.com/index.php?rid=3168826&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS003763371070022X%2Fabstract%3Frss%3Dyes SEATTLE — Successful reconstruction of facial defects created by Mohs surgery requires knowledge not only of appropriate operative techniques, but also of patients and their cancers. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3168826 Fri, 01 Jan 2010 00:00:00 +0100 3168826 http://www.medworm.com/index.php?rid=3168825&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633710700218%2Fabstract%3Frss%3Dyes PHOENIX — Dermatologists may be under the clinical impression that botulinum toxin is better suited for the upper face, while fillers are the treatment of choice for the lower face. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3168825 Fri, 01 Jan 2010 00:00:00 +0100 3168825 http://www.medworm.com/index.php?rid=3168824&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633710700206%2Fabstract%3Frss%3Dyes The National Institutes of Health has awarded a $1.77 million grant to Pratima Karnik, Ph.D. (Case Western Reserve University, Cleveland) for a 5-year study of cicatricial alopecia. The study, “PPAR-gamma Signaling in Normal Pilosebaceous Units and in Scarring Alopecia,” is a continuation of collaborative scientific research linking a defect in lipid processing and peroxisome biogenesis to rare and painful hair loss disorders. The preliminary studies provided insight into highly complex interaction between hair follicle cells and environmental factors that may cause cicatricial alopecia. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3168824 Fri, 01 Jan 2010 00:00:00 +0100 3168824 http://www.medworm.com/index.php?rid=3168823&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS003763371070019X%2Fabstract%3Frss%3Dyes PHOENIX — Some devices commonly touted for skin tightening are supported by evidence-based medicine, although few have data at the randomized, controlled-trial level, according to Dr. E. Victor Ross. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3168823 Fri, 01 Jan 2010 00:00:00 +0100 3168823 http://www.medworm.com/index.php?rid=3168822&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633710700188%2Fabstract%3Frss%3Dyes DR. BAUMANN is in private practice in Miami Beach. To respond to this column, or to suggest topics for future columns, write to Dr. Baumann at our editorial offices via e-mail at sknews@elsevier.com. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3168822 Fri, 01 Jan 2010 00:00:00 +0100 3168822 http://www.medworm.com/index.php?rid=3168821&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633710700176%2Fabstract%3Frss%3Dyes MS. CARTER (D-Rialto) is a member of the California State Assembly representing District 62. She sponsored the Donda West Law. On Oct. 11, 2009, California Gov. Arnold Schwarzenegger signed into law a bill requiring a health check and a written clearance before patients can undergo plastic surgery. Assembly bill 1116, the Donda West Law, was inspired by the death of entertainer Kanye West's mother, Donda West, who was the former chairwoman of the Chicago State University English department. She died on Nov. 10, 2007, because of complications from cosmetic surgery. A physical was not performed before she underwent surgery. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3168821 Fri, 01 Jan 2010 00:00:00 +0100 3168821 http://www.medworm.com/index.php?rid=3168820&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633710700164%2Fabstract%3Frss%3Dyes DR. ROCKOFF practices dermatology in Brookline, Mass. To respond to this column, email Dr. Rockoff at our editorial offices at sknews@elsevier.com. Probably like many who work with the public, I often get the chance to see how little sense people can make. Even so, last week was unusual. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3168820 Fri, 01 Jan 2010 00:00:00 +0100 3168820 http://www.medworm.com/index.php?rid=3168819&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633710700152%2Fabstract%3Frss%3Dyes DR. ZACHARY is professor and chair of the department of dermatology at the University of California, Irvine. Any talk of health care reform must include a discussion of the money we're currently wasting on health care regulation. Recent data suggest that 47-60 million Americans are without health insurance. Many people avoid seeking health care because it is too costly. If they do seek care, many become burdened by high costs. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3168819 Fri, 01 Jan 2010 00:00:00 +0100 3168819 http://www.medworm.com/index.php?rid=3168818&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633710700140%2Fabstract%3Frss%3Dyes GAITHERSBURG, MD. — Black box warnings added to the labels of all gadolinium-based MRI contrast agents have reduced the number of reported nephrogenic systemic fibrosis events to almost none in the last year, according to Dr. James Kaiser. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3168818 Fri, 01 Jan 2010 00:00:00 +0100 3168818 http://www.medworm.com/index.php?rid=3168817&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633710700139%2Fabstract%3Frss%3Dyes BERLIN — The threshold for developing nephrogenic systemic fibrosis in response to gadolinium deposition in skin and other tissues appears to be much broader than previously recognized, according to Dr. Mark R. Pittelkow. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3168817 Fri, 01 Jan 2010 00:00:00 +0100 3168817 http://www.medworm.com/index.php?rid=3168816&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633710700127%2Fabstract%3Frss%3Dyes New guidelines issued by the European League Against Rheumatism on the monitoring of patients with systemic lupus erythematosus offer advice for clinicians and recommendations for the design of observational studies. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3168816 Fri, 01 Jan 2010 00:00:00 +0100 3168816 http://www.medworm.com/index.php?rid=3168815&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633710700115%2Fabstract%3Frss%3Dyes The National Institute of Allergy and Infectious Diseases has awarded $1.6 million to Signum Biosciences Inc. The company will use the grant to continue its development of topical STM (signal transduction modulator) anti-inflammatory technology for the treatment of rosacea. For more information, contact Signum at www.signumbiosciences.com. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3168815 Fri, 01 Jan 2010 00:00:00 +0100 3168815 http://www.medworm.com/index.php?rid=3168814&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633710700103%2Fabstract%3Frss%3Dyes The American Academy of Dermatology is phasing out its “Seal of Recognition” program, partly because a low participation rate meant that it was not meeting the AAD's goals, according to AAD President David Pariser. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3168814 Fri, 01 Jan 2010 00:00:00 +0100 3168814 http://www.medworm.com/index.php?rid=3168813&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633710700097%2Fabstract%3Frss%3Dyes PHILADELPHIA — Women with rheumatic disease who took etanercept during pregnancy were three times more likely to have a child with a major malformation than a disease-matched comparison group, judging from interim results from a small sample. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3168813 Fri, 01 Jan 2010 00:00:00 +0100 3168813 http://www.medworm.com/index.php?rid=3168812&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633710700085%2Fabstract%3Frss%3Dyes PHILADELPHIA — Treatment with golimumab reversed structural joint damage in patients with psoriatic arthritis in a placebo-controlled, phase III study of over 400 patients. The structural joint benefit from golimumab in this analysis complemented clinical improvements previously reported from the same study. Those benefits led the Food and Drug Administration to give marketing approval to golimumab for psoriatic arthritis (PsA) last April. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3168812 Fri, 01 Jan 2010 00:00:00 +0100 3168812 http://www.medworm.com/index.php?rid=3168811&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633710700073%2Fabstract%3Frss%3Dyes BERLIN — Bosentan appears to be effective for reduction of skin fibrosis in patients with systemic sclerosis. Ten patients with systemic sclerosis showed a significant decrease in the skin-thickening characteristic of the disease in response to treatment with bosentan (Tracleer) in a prospective open-label study, Dr. Annegret Kuhn reported at the annual congress of the European Academy of Dermatology and Venereology. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3168811 Fri, 01 Jan 2010 00:00:00 +0100 3168811 http://www.medworm.com/index.php?rid=3168810&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633710700061%2Fabstract%3Frss%3Dyes BERLIN — Clonal T cell populations may play a key role in the pathogenesis of systemic sclerosis. Expanded populations of clonal T cells were detected by high-resolution capillary electrophoresis and polymerase chain reaction in the peripheral blood of 61% of 126 patients with systemic sclerosis, Dr. Alexander Kreuter reported at the annual congress of the European Academy of Dermatology and Venereology. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3168810 Fri, 01 Jan 2010 00:00:00 +0100 3168810 http://www.medworm.com/index.php?rid=3168809&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS003763371070005X%2Fabstract%3Frss%3Dyes Disclosures: Dr. Baumann has served as an investigator, adviser, and speaker for a number of pharmaceutical companies. Dr. Gottlieb has received research grants from Celgene Corporation, manufacturer of Apremilast, and Centocor, manufacturer of golimumab (Simponi). Dr. Goldberg has no conflicts of interest, and Dr. Sengelmann had no relevant conflicts of interest to report. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3168809 Fri, 01 Jan 2010 00:00:00 +0100 3168809 http://www.medworm.com/index.php?rid=3168808&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633710700048%2Fabstract%3Frss%3Dyes (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3168808 Fri, 01 Jan 2010 00:00:00 +0100 3168808 http://www.medworm.com/index.php?rid=3168807&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633710700036%2Fabstract%3Frss%3Dyes Skin & Allergy News is changing its look and content to meet your information needs. Over the last year, we listened as our readers and editorial advisers described how they want to read the news. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3168807 Fri, 01 Jan 2010 00:00:00 +0100 3168807 http://www.medworm.com/index.php?rid=3168806&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633710700322%2Fabstract%3Frss%3Dyes A 47-year-old woman with a previously reported biopsy diagnosis of pityriasis rubra pilaris presented with aggravation of a scaling, papular eruption. What's your diagnosis? 31 (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3168806 Fri, 01 Jan 2010 00:00:00 +0100 3168806 http://www.medworm.com/index.php?rid=3168805&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633710700024%2Fabstract%3Frss%3Dyes CHICAGO — An ultrasound technique that measures tissue elasticity could dramatically alter the way in which skin cancer is diagnosed. In a prospective study of 56 patients with proliferative malignant neoplasms or benign skin lesions, the use of ultrasound elastography analysis prior to biopsy correctly differentiated benign from malignant lesions in 100% of cases (P value equal .0007), Dr. Eliot Siegel reported at the annual meeting of the Radiological Society of North America. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3168805 Fri, 01 Jan 2010 00:00:00 +0100 3168805 http://www.medworm.com/index.php?rid=3168804&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633710700012%2Fabstract%3Frss%3Dyes As the Senate continued to debate the Democrats' health reform proposal, it was not clear whether a proposed 5% tax on elective cosmetic surgery, including injectables, would survive the floor fight and the eventual conference committee to reconcile the House and Senate bills. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3168804 Fri, 01 Jan 2010 00:00:00 +0100 3168804 http://www.medworm.com/index.php?rid=3058063&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS003763370970631X%2Fabstract%3Frss%3Dyes PORTLAND, ORE. — On exam, scattered, dome-shaped, smooth, discrete, dark red-brown to blue-black papules and macules were noted, ranging in size from 0.5 to 4.0 mm in diameter, Dr. Kevin P. White said at the annual meeting of the Pacific Dermatologic Association. A total of about 40 lesions were clustered predominantly over the buttocks, sacrum, lower back, and upper posterior and inner thighs. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3058063 Tue, 01 Dec 2009 00:00:00 +0100 3058063 http://www.medworm.com/index.php?rid=3058062&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709706308%2Fabstract%3Frss%3Dyes Finacea's (azelaic acid gel 15%) Web site has been revamped. The new site offers information about rosacea and the product, which is approved by the Food and Drug Administration for treating the redness, bumps, and pustules associated with mild to moderate rosacea. Visitors to the site can find skin care advice and streaming video from dermatologists, and can subscribe to an e-newsletter. The site also provides a questionnaire and a rosacea triggers assessment tool that patients can complete and bring with them to their dermatologist's office. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3058062 Tue, 01 Dec 2009 00:00:00 +0100 3058062 http://www.medworm.com/index.php?rid=3058061&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709706291%2Fabstract%3Frss%3Dyes As a child growing up in Toledo, Ohio, Dr. Stanford T. Shulman became fascinated with collecting postage stamps because they combined his interests in history and geography. “One of the best ways to learn history and geography is from stamps from around the world,” said Dr. Shulman, chief of the division of infectious diseases at Children's Memorial Hospital, Chicago. Postage stamps “are colorful, they all tell a story, and you can learn a whole lot from them, whether you want to have a butterfly stamp collection, an elephant stamp collection, or a medicine stamp collection.” (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3058061 Tue, 01 Dec 2009 00:00:00 +0100 3058061 http://www.medworm.com/index.php?rid=3058060&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS003763370970628X%2Fabstract%3Frss%3Dyes The American Academy of Dermatology has launched a new Web site to teach children aged 8–12 years about healthy habits for their skin, hair, and nails. The site includes a game based on the life of Sammy the skin cell, a skin dictionary, and quick facts. The site also features safety tips for manicures, the dangers of tattoos, eczema treatments, and more. For more information, visit www.kidsskinhealth.org. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3058060 Tue, 01 Dec 2009 00:00:00 +0100 3058060 http://www.medworm.com/index.php?rid=3058059&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709706278%2Fabstract%3Frss%3Dyes The Federal Trade Commission once again has delayed enforcement of the Red Flags Rule, giving physicians until June 1, 2010, before they have to comply with new requirements aimed at preventing identity theft. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3058059 Tue, 01 Dec 2009 00:00:00 +0100 3058059 http://www.medworm.com/index.php?rid=3058058&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709706254%2Fabstract%3Frss%3Dyes Dr. Eastern practices dermatology and dermatologic surgery in Belleville, N.J. To respond to this column, e-mail Dr. Eastern at sknews@elsevier.com. A dermatologist recently sought my input regarding his two-physician private practice on the West Coast. They were struggling with an increasing problem, he said, of employees sending personal text messages and surfing the Internet during office hours. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3058058 Tue, 01 Dec 2009 00:00:00 +0100 3058058 http://www.medworm.com/index.php?rid=3058057&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709706266%2Fabstract%3Frss%3Dyes Legislation that would have provided a 10-year replacement of Medicare's sustainable growth rate formula was blocked when senators voted 53–47 against bringing the bill to the floor. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3058057 Tue, 01 Dec 2009 00:00:00 +0100 3058057 http://www.medworm.com/index.php?rid=3058056&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709706242%2Fabstract%3Frss%3Dyes Can't get enough Policy & Practice? Check out our new podcast each Monday. egmnblog.wordpress.com Allergan just reported its third-quarter earnings, and although Botox (onabotulinumtoxinA) sales increased a scant 3%, the company said that the injectable contributed to a net profit rise of 8.3%. The company predicted that its total Botox sales for the year would be almost $1.3 billion. Also in the third quarter, Allergan filed for Food and Drug Administration approval to promote the use of Botox for migraine headaches and submitted additional data to the agency on the drug's use for upper limb spasticity. Allergan also stated that it expects sales of the eyelash lengthener Latisse (bimatoprost) to hit $70 million for the year. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3058056 Tue, 01 Dec 2009 00:00:00 +0100 3058056 http://www.medworm.com/index.php?rid=3058055&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709706230%2Fabstract%3Frss%3Dyes BERLIN — Ustekinumab and adalimumab exhibited similar efficacy and safety in a matching-adjusted comparison of outcomes across major clinical trials in psoriasis. There was, however, a difference in drug costs per responder at 12 weeks. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3058055 Tue, 01 Dec 2009 00:00:00 +0100 3058055 http://www.medworm.com/index.php?rid=3058054&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709706229%2Fabstract%3Frss%3Dyes BERLIN — Infliximab is effective for the treatment of refractory psoriasis of the palms and soles, a small randomized trial found. This was the first-ever formal study of infliximab specifically in the setting of palmoplantar psoriasis, a condition that is notoriously tough to treat, said Dr. Robert Bissonnette, president of a clinical research company in Montreal. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3058054 Tue, 01 Dec 2009 00:00:00 +0100 3058054 http://www.medworm.com/index.php?rid=3058053&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709706217%2Fabstract%3Frss%3Dyes BERLIN — Patients with nail psoriasis have been found to respond to infliximab in parallel with cutaneous improvement, according to the results of a new post hoc analysis of a phase III study. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3058053 Tue, 01 Dec 2009 00:00:00 +0100 3058053 http://www.medworm.com/index.php?rid=3058052&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709706205%2Fabstract%3Frss%3Dyes The American Academy of Dermatology's latest guidelines on the management of psoriasis and psoriatic arthritis focus on phototherapy. Despite therapeutic advances in recent years, phototherapy remains an important treatment option for patients with psoriasis, according to Dr. Alan Menter, chairman of the division of dermatology at Baylor University Medical Center in Dallas, and his associates. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3058052 Tue, 01 Dec 2009 00:00:00 +0100 3058052 http://www.medworm.com/index.php?rid=3058051&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709706199%2Fabstract%3Frss%3Dyes BOSTON — There are still unanswered questions about the association between biologic drugs and the risk of lymphoma, but published data suggest that benefits outweigh risks for psoriasis patients, said Dr. Joel M. Gelfand. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3058051 Tue, 01 Dec 2009 00:00:00 +0100 3058051 http://www.medworm.com/index.php?rid=3058050&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709706187%2Fabstract%3Frss%3Dyes BUDAPEST, HUNGARY — Narrow-band UVB therapy for psoriasis or atopic dermatitis not only improves the skin disease, but also corrects the serum vitamin D deficiency that is ubiquitous in patients with these dermatologic disorders, particularly during the winter months in northern latitudes, according to Dr. Katja Vhvihu. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3058050 Tue, 01 Dec 2009 00:00:00 +0100 3058050 http://www.medworm.com/index.php?rid=3058049&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709706175%2Fabstract%3Frss%3Dyes PHOENIX — Cosmetic dermatology procedures require patient education and thorough consent, a panel of four physicians agreed during a discussion of how best to manage any complications that do occur. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3058049 Tue, 01 Dec 2009 00:00:00 +0100 3058049 http://www.medworm.com/index.php?rid=3058048&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709706163%2Fabstract%3Frss%3Dyes PHOENIX — Cosmetic dermatologists need to remain ethical in how they choose and promote a product or procedure, as well as how they market their practice to patients, according to Dr. Susan H. Weinkle. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3058048 Tue, 01 Dec 2009 00:00:00 +0100 3058048 http://www.medworm.com/index.php?rid=3058047&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709706151%2Fabstract%3Frss%3Dyes PHOENIX — Adding laser lipolysis to radiofrequency tightening procedures for submental and jowl area fat did not significantly increase patient satisfaction, based on the results of a small study. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3058047 Tue, 01 Dec 2009 00:00:00 +0100 3058047 http://www.medworm.com/index.php?rid=3058046&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS003763370970614X%2Fabstract%3Frss%3Dyes PHOENIX — Patient satisfaction following injection of poly-l-lactic acid for aesthetic indications increases with the number of treatment sessions, according to a retrospective study. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3058046 Tue, 01 Dec 2009 00:00:00 +0100 3058046 http://www.medworm.com/index.php?rid=3058045&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709706138%2Fabstract%3Frss%3Dyes Phoenix — Fractional CO2 lasers provide greater accuracy, control, and predictability for skin resurfacing than do chemical peels, according to Dr. Kimberly Butterwick. However, Dr. Gary Monheit countered that peels are more efficient, safe, and reliable than lasers. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3058045 Tue, 01 Dec 2009 00:00:00 +0100 3058045 http://www.medworm.com/index.php?rid=3058044&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709706126%2Fabstract%3Frss%3Dyes Dr. Baumann is in private practice in Miami Beach. To respond to this column, or to suggest topics for future columns, write to Dr. Baumann at our editorial offices via e-mail at sknews@elsevier.com. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3058044 Tue, 01 Dec 2009 00:00:00 +0100 3058044 http://www.medworm.com/index.php?rid=3058043&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709706114%2Fabstract%3Frss%3Dyes OnabotulinumtoxinA administered via a sponge inserted into the nasal cavity may reduce symptoms in some patients with refractory idiopathic rhinitis, according to a small German study. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3058043 Tue, 01 Dec 2009 00:00:00 +0100 3058043 http://www.medworm.com/index.php?rid=3058042&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709706102%2Fabstract%3Frss%3Dyes SAN DIEGO — Lichen sclerosus is often asymptomatic, but the most common symptom is pruritus. “It can be such severe itching that they're scratching in their sleep,” Dr. Hope K. Haefner said at the annual meeting of the North American Menopause Society. “We see people with nail marks where tissue is gone. In children we tend to see pruritus ani.” (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3058042 Tue, 01 Dec 2009 00:00:00 +0100 3058042 http://www.medworm.com/index.php?rid=3058041&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709706096%2Fabstract%3Frss%3Dyes Repairing skin barrier dysfunction due to environmental exposures and endogenous factors is essential for the management of hand dermatitis. The dysfunction also may be iatrogenic, which adds to morbidity by making the underlying eczema much harder to treat, Dr. Joseph F. Fowler Jr. explained at the women's and pediatric dermatology seminar sponsored by Skin Disease Education Foundation. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3058041 Tue, 01 Dec 2009 00:00:00 +0100 3058041 http://www.medworm.com/index.php?rid=3058040&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709706084%2Fabstract%3Frss%3Dyes BERLIN — A single blast of terbinafine 1% spray consistently decontaminated shoe insoles colonized by Trichophyton rubrum–infected skin scales. Applying a topical antifungal agent to shoes may lessen or prevent tinea pedis in patients with dermatophytosis, Dr. Martine Feuilhade de Chauvin reported at the annual congress of the European Academy of Dermatology and Venereology. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3058040 Tue, 01 Dec 2009 00:00:00 +0100 3058040 http://www.medworm.com/index.php?rid=3058039&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709706072%2Fabstract%3Frss%3Dyes Phoenix — Dermatologists can easily and effectively repigment the skin of patients with segmental or focal vitiligo, according to a study that demonstrated an 87% graft survival rate. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3058039 Tue, 01 Dec 2009 00:00:00 +0100 3058039 http://www.medworm.com/index.php?rid=3058038&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709706060%2Fabstract%3Frss%3Dyes ATLANTA — The Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices recommended a bivalent human papillomavirus vaccine as an alternative to the quadrivalent vaccine for the prevention of cervical cancer and related precancerous conditions in women and girls aged 9–26 years. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3058038 Tue, 01 Dec 2009 00:00:00 +0100 3058038 http://www.medworm.com/index.php?rid=3058037&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709706059%2Fabstract%3Frss%3Dyes A vaccine that contained peptides targeting the human papillomavirus-16 oncoproteins E6 and E7 was effective against high-grade, HPV-16–positive vulvar intraepithelial neoplasia, according to the results of a small phase II study. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3058037 Tue, 01 Dec 2009 00:00:00 +0100 3058037 http://www.medworm.com/index.php?rid=3058036&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709706047%2Fabstract%3Frss%3Dyes Genetic mutations that impair dectin-1 function have been tied to susceptibility to fungal infection in two families, according to two separate reports. In the first study, genetic assessments were performed in a large, consanguineous Iranian family to determine whether a mutated gene was responsible for their nonsyndromic fungal infections, noted Dr. Erik-Oliver Glocker of Royal Free Hospital and University College London and his associates. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3058036 Tue, 01 Dec 2009 00:00:00 +0100 3058036 http://www.medworm.com/index.php?rid=3058035&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709706035%2Fabstract%3Frss%3Dyes The American Medical Association has launched an interactive Web site for the public to evaluate the severity of influenza symptoms of individuals or family members and share that information with their health care providers, who in turn can use the site to monitor their patients' symptoms, the AMA announced during a telephone briefing. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3058035 Tue, 01 Dec 2009 00:00:00 +0100 3058035 http://www.medworm.com/index.php?rid=3058034&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709706023%2Fabstract%3Frss%3Dyes Collection of an oseltamivir-resistant pandemic influenza A(H1N1) isolate in a 59-year-old man taking the drug prophylactically underscores the need to limit antiviral prophylaxis of pandemic flu, according to correspondence published online in the New England Journal of Medicine on Nov. 11. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3058034 Tue, 01 Dec 2009 00:00:00 +0100 3058034 http://www.medworm.com/index.php?rid=3058033&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709706011%2Fabstract%3Frss%3Dyes Americans may need to brace for a long winter of “rising and falling” waves of pandemic influenza A(H1N1) outbreaks, Kathleen Sebelius, Secretary of the Department of Health and Human Services, warned during a telebriefing. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3058033 Tue, 01 Dec 2009 00:00:00 +0100 3058033 http://www.medworm.com/index.php?rid=3058032&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS003763370970600X%2Fabstract%3Frss%3Dyes Health care workers harbor significant fears and misconceptions about influenza vaccination, according to the results of a survey conducted at a large tertiary children's hospital in the Midwestern United States. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3058032 Tue, 01 Dec 2009 00:00:00 +0100 3058032 http://www.medworm.com/index.php?rid=3058031&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705996%2Fabstract%3Frss%3Dyes BERLIN — The addition of bevacizumab to chemotherapy failed to significantly improve progression-free or overall survival in previously untreated advanced melanoma in the phase II BEAM trial. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3058031 Tue, 01 Dec 2009 00:00:00 +0100 3058031 http://www.medworm.com/index.php?rid=3058030&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705984%2Fabstract%3Frss%3Dyes Seattle — Evidence from recent and ongoing trials is helping to clarify the best strategies for managing cutaneous melanoma. A hurdle to better melanoma management has been the high variability of the disease, exemplified in part by its wide-ranging presentations, said Dr. William Dzwierzynski, professor of plastic and reconstructive surgery at the Medical College of Wisconsin in Milwaukee. In fact, accumulating evidence suggests that melanoma may encompass several different diseases with differing biology. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3058030 Tue, 01 Dec 2009 00:00:00 +0100 3058030 http://www.medworm.com/index.php?rid=3058029&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705972%2Fabstract%3Frss%3Dyes Dr. Brennan is the national program director for Project HealthDesign, a national program of the Robert Wood Johnson Foundation, and Lillian L. Moehlman Bascom Professor, School of Nursing and College of Engineering, University of Wisconsin, Madison. Dr. Jaén is professor and chairman of the department of family and community medicine at the University of Texas Health Science Center at San Antonio and serves on the national advisory committee for Project HealthDesign. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3058029 Tue, 01 Dec 2009 00:00:00 +0100 3058029 http://www.medworm.com/index.php?rid=3058028&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705960%2Fabstract%3Frss%3Dyes Dr. Rockoff practices dermatology in Brookline, Mass. To respond to this column, e-mail Dr. Rockoff at sknews@elsevier.com. Rosalie hadn't been by in 3 years. Her chief concern was a growth on her forearm. Then she pointed to a cholesterol deposit above her right eye. “I thought it might have been from crying,” she said. “My daughter died 14 months ago. She was 26.” (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3058028 Tue, 01 Dec 2009 00:00:00 +0100 3058028 http://www.medworm.com/index.php?rid=3058027&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705959%2Fabstract%3Frss%3Dyes Dr. Levy is with the division of general internal medicine and McKusick-Nathans Institute of Genetic Medicine at Johns Hopkins University, Baltimore. The expanding market for direct-to-consumer genetic testing raises important issues that physicians, patients, and policy makers are just starting to address. I consider DTC marketing of genetic information a natural evolution of technology, and a development that may offer benefits for individuals and society. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3058027 Tue, 01 Dec 2009 00:00:00 +0100 3058027 http://www.medworm.com/index.php?rid=3058026&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705947%2Fabstract%3Frss%3Dyes SAN DIEGO — Isotretinoin use was associated with a 68% increased risk for subsequent development of inflammatory bowel disease, particularly ulcerative colitis, in a retrospective case-control study of 30,021 patients. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3058026 Tue, 01 Dec 2009 00:00:00 +0100 3058026 http://www.medworm.com/index.php?rid=3058025&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705935%2Fabstract%3Frss%3Dyes BERLIN — Oral ivermectin proved superior to conventional therapy with malathion lotion for the treatment of difficult to eradicate head lice infestations in a large multinational randomized trial. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3058025 Tue, 01 Dec 2009 00:00:00 +0100 3058025 http://www.medworm.com/index.php?rid=3058024&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705923%2Fabstract%3Frss%3Dyes PHILADELPHIA — Two studies showed an increased risk for nonmelanoma skin cancer in patients who take anti–tumor necrosis factor therapies, and should prompt physicians to evaluate the use of these drugs in patients who are at risk for skin cancer, according to the researchers. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3058024 Tue, 01 Dec 2009 00:00:00 +0100 3058024 http://www.medworm.com/index.php?rid=3058023&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705911%2Fabstract%3Frss%3Dyes Significantly more lupus patients responded to belimumab than placebo in a randomized trial with more than 800 patients followed for a year, the second positive outcome from a pivotal trial of the investigational monoclonal antibody in lupus this year. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3058023 Tue, 01 Dec 2009 00:00:00 +0100 3058023 http://www.medworm.com/index.php?rid=3058022&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS003763370970590X%2Fabstract%3Frss%3Dyes The Food and Drug Administration issued its first-ever draft guidance for pharmaceutical manufacturers on how to develop a Risk Evaluation and Mitigation Strategy, which the agency increasingly requires of newly approved drugs and biologics. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3058022 Tue, 01 Dec 2009 00:00:00 +0100 3058022 http://www.medworm.com/index.php?rid=3058021&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705893%2Fabstract%3Frss%3Dyes SILVER SPRING, MD. — Reducing preventable injuries from medication errors, misuse, and abuse is the goal of an initiative being launched by the Food and Drug Administration, agency officials announced. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3058021 Tue, 01 Dec 2009 00:00:00 +0100 3058021 http://www.medworm.com/index.php?rid=3058020&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705881%2Fabstract%3Frss%3Dyes The Food and Drug Administration wants more information before it rules on a supplemental Biologics License Application for pegylated interferon alfa-2b in stage III melanoma. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3058020 Tue, 01 Dec 2009 00:00:00 +0100 3058020 http://www.medworm.com/index.php?rid=3058019&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS003763370970587X%2Fabstract%3Frss%3Dyes (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3058019 Tue, 01 Dec 2009 00:00:00 +0100 3058019 http://www.medworm.com/index.php?rid=3058018&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705868%2Fabstract%3Frss%3Dyes At a meeting convened by the Food and Drug Administration, pharmaceutical and medical device manufacturers, advertisers, medical Web site owners, search engine companies, and consumer advocates all argued for greater regulation of health-specific content on the Internet, including social media sites. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3058018 Tue, 01 Dec 2009 00:00:00 +0100 3058018 http://www.medworm.com/index.php?rid=3058017&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705856%2Fabstract%3Frss%3Dyes A healthy 31-year-old woman from eastern Oregon presented with a 3- to 4-month history of multiple, new, asymptomatic “moles” over her buttocks, thighs, and lower torso. Besides delivering a baby 10 months prior, her past medical history and review of systems was noncontributory except for gestational diabetes that was controlled at the time with metformin. What's your diagnosis? See Case of the Month, page 43. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3058017 Tue, 01 Dec 2009 00:00:00 +0100 3058017 http://www.medworm.com/index.php?rid=3058016&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705844%2Fabstract%3Frss%3Dyes BERLIN — Psoriasis patients who show less than a PASI-50 response to 20 mg/wk of methotrexate by week 12 are unlikely to benefit from dosage increases or longer therapy, according to a new analysis of the CHAMPION study. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3058016 Tue, 01 Dec 2009 00:00:00 +0100 3058016 http://www.medworm.com/index.php?rid=3058015&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705832%2Fabstract%3Frss%3Dyes BERLIN — Atopic dermatitis is strongly and independently associated with attention-deficit/hyperactivity disorder, three large German studies suggest. If the relationship is causal—and that's an unsettled issue—then atopic dermatitis would explain roughly 10% of all cases of ADHD, Dr. Jochen Schmitt estimated at the annual congress of the European Academy of Dermatology and Venereology. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=3058015 Tue, 01 Dec 2009 00:00:00 +0100 3058015 http://www.medworm.com/index.php?rid=2960765&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705820%2Fabstract%3Frss%3Dyes PORTLAND, ORE. — The patient's oral lesions began with minor induration and ulceration along the closure line of teeth on the buccal mucosa, according to Dr. Bruce D. Ragsdale, who presented the case at the annual meeting of the Pacific Dermatologic Association. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960765 Sun, 01 Nov 2009 00:00:00 +0100 2960765 http://www.medworm.com/index.php?rid=2960764&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705819%2Fabstract%3Frss%3Dyes The federal government has issued new rules spelling out how it intends to police the use of genetic information by health plans. The new regulations bar health insurers from increasing premiums or denying enrollment based on genetic information. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960764 Sun, 01 Nov 2009 00:00:00 +0100 2960764 http://www.medworm.com/index.php?rid=2960763&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705807%2Fabstract%3Frss%3Dyes Really Really Clean facial cleanser features a unique combination of 17 amino acids that provide the skin with important nutrients. The formula is designed for deep facial cleansing to remove dirt, makeup, and impurities. In addition, the cleanser helps maintain the natural balance of the skin, with a moisturizing element that protects the skin's surface. The cleanser can be used in the morning and evening to prepare the skin for other daily care or overnight products, and it also can be used in the shower as a total body wash. The cleanser can also serve as a shaving gel that helps to prevent razor burn and bumps. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960763 Sun, 01 Nov 2009 00:00:00 +0100 2960763 http://www.medworm.com/index.php?rid=2960762&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705790%2Fabstract%3Frss%3Dyes Bruise Relief is available for eliminating the appearance of bruising and skin discoloration by super hydrating the skin, which helps prevent the pooling of blood and facilitate the reabsorption of blood at bruise sites. It is not an analgesic. The topical skin care product is recommended by physicians and plastic surgeons to reduce bruising that results from injury or minor surgery, as well as the appearance of dark circles and under-eye darkness resulting from stress, lack of sleep, and cosmetic procedures. The product is available in gel and serum formulations that are safe for all ages and all skins types. The product retails for about $18. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960762 Sun, 01 Nov 2009 00:00:00 +0100 2960762 http://www.medworm.com/index.php?rid=2960761&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705789%2Fabstract%3Frss%3Dyes Kinerase Scar Healing Therapy is available for improving the appearance, color, roughness, and discomfort of old and new scars. It is a concentrated, nongreasy silicone gel that forms an invisible protective barrier to soften, flatten, and smooth scars and reduce the appearance of scar-related skin discoloration. It also helps to normalize collagen deposition by restoring the barrier function to the skin. The gel contains the emollient cyclopentasiloxane; three silicones that form an occlusive barrier on the skin; and a stable lipophilic form of vitamin C that may promote collagen synthesis, prevent lipid peroxidation, and inhibit tyrosinase activity. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960761 Sun, 01 Nov 2009 00:00:00 +0100 2960761 http://www.medworm.com/index.php?rid=2960760&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705777%2Fabstract%3Frss%3Dyes The DermaMinerals makeup line is available for improving skin barrier function and minimizing the appearance of wrinkles and fine lines. It contains Archipelago Sea minerals, Dermaxyl peptide, boron nitride, mica-wrapped cotton fibers, and honeysuckle extract. The makeup collection includes foundation, powder (loose and pressed), eye shadow, blush, lipstick, bronzer, and concealer, as well as nine brushes and eye-makeup remover. The products do not contain paraben, and are not tested on animals. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960760 Sun, 01 Nov 2009 00:00:00 +0100 2960760 http://www.medworm.com/index.php?rid=2960759&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705765%2Fabstract%3Frss%3Dyes Lumixyl is available for improving the appearance of hyperpigmentation, including melasma, sun spots, photodamage, age spots, liver spots, postinflammatory hyperpigmentation, and hyperpigmentation caused by systemic disease or prescription drugs. It is nontoxic, nonirritating, water soluble, and safe for all skin types. Formulated as an over-the-counter cream, Lumixyl is an alternative to hydroquinone, and is the only peptide capable of directly inhibiting tyrosinase, the enzyme responsible for initiating melanin synthesis in skin. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960759 Sun, 01 Nov 2009 00:00:00 +0100 2960759 http://www.medworm.com/index.php?rid=2960758&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705753%2Fabstract%3Frss%3Dyes Occulus Innovative Services has received an expanded clearance from the Food and Drug Administration to market its Microcyn Skin and Wound HydroGel in prescription and over-the-counter formulations. The product, based on the Microcyn technology, is indicated for managing the debridement of wounds such as leg, pressure, and diabetic ulcers, and postsurgical wounds, first- and second-degree wounds, and grafted and donor sites. In addition to its wound-healing benefits, Microcyn technology is safe, and works to reduce inflammation and rapidly improve antimicrobial activity. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960758 Sun, 01 Nov 2009 00:00:00 +0100 2960758 http://www.medworm.com/index.php?rid=2960757&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705741%2Fabstract%3Frss%3Dyes Acne patients may be at increased risk for sun sensitivity and skin damage, depending on their treatment regimen. The Avidoxy DK defence kit offers products that provide sun protection for acne suffers without exacerbating their condition. The kit consists of 100-mg doxycycline tablets (available by prescription only) to help destroy acne-causing bacteria, plus two free products: defence acne wash and defence solare SPF 30. The acne wash contains 2% salicylic acid to promote cleansing and exfoliation, and it is oil-free and alcohol-free. The defence solare SPF is an oil-free, noncomedogenic, moisturizing sunblock that contains antioxidants and zinc oxide to provide broad-spectrum sun protection for acne-prone skin. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960757 Sun, 01 Nov 2009 00:00:00 +0100 2960757 http://www.medworm.com/index.php?rid=2960756&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS003763370970573X%2Fabstract%3Frss%3Dyes Neutrogena's Skin ID regimen is available to treat and help prevent acne. The three-product, over-the-counter system is offered as an alternative to antibiotics for those who are concerned about building resistance to antibiotic treatments. Customers can complete an online skin evaluation that will direct them to a gel cleanser, an acne treatment, and a moisturizer “personalized” to fit their skin condition. The regimen includes salicylic acid, benzoyl peroxide, and a proprietary MicroClear technology to deliver the medication deep into pores; the system retails for about $40. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960756 Sun, 01 Nov 2009 00:00:00 +0100 2960756 http://www.medworm.com/index.php?rid=2960755&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705728%2Fabstract%3Frss%3Dyes La Roche-Posay's Effaclar AI Intensive Acne Spot Treatment is available to reduce stubborn and inflammatory acne in as few as 3 days. The formulation includes a 5.5% concentration of micronized benzoyl peroxide to clear inflammatory acne, as well as 0.4% LHA (lipohydroxy acid), which is a lipophilic derivative of salicylic acid that micro-exfoliates the skin and stimulates cell renewal to help even the skin tone, including residual skin marking. The product is oil free and noncomedogenic, and has been tested on sensitive skin. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960755 Sun, 01 Nov 2009 00:00:00 +0100 2960755 http://www.medworm.com/index.php?rid=2960754&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705716%2Fabstract%3Frss%3Dyes DNA Repair Factor Nourishing Lotion combines a patented copper peptide formula with advanced DNA repair and moisturizing properties to help regenerate skin and reverse signs of damage. The lotion's restorative activity is supported by an amino acid system that combines glycine, proline, and alanine in a form similar to collagen. The lotion is designed to identify and repair indirect DNA damage from free radicals and cell oxidation, as well as direct DNA damage from cyclobutane pyrimidine dimers. The hydrating and correcting formula is suitable for all skin types, but it may be especially helpful for mature and photodamaged skin. The lotion may be applied twice daily, after cleansing the skin in the morning and in the evening. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960754 Sun, 01 Nov 2009 00:00:00 +0100 2960754 http://www.medworm.com/index.php?rid=2960753&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705704%2Fabstract%3Frss%3Dyes This month, physicians in Ohio and New Jersey will begin to test a single, online portal through which they can access health insurance eligibility and benefits information for most of their privately insured patients. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960753 Sun, 01 Nov 2009 00:00:00 +0100 2960753 http://www.medworm.com/index.php?rid=2960752&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705698%2Fabstract%3Frss%3Dyes A continued wide disparity in access to and quality of care across the United States argues strongly for a national health reform plan, according to executives at the Commonwealth Fund, who released a state-by-state survey of 38 health indicators. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960752 Sun, 01 Nov 2009 00:00:00 +0100 2960752 http://www.medworm.com/index.php?rid=2960751&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705686%2Fabstract%3Frss%3Dyes ROSEMONT, ILL. — Despite major patient safety strides during the past decade, health care providers need to create more accountability for medical errors and patient safety lapses in order to continue improving, according to Dr. Robert M. Wachter, professor and associate chairman of medicine at the University of California, San Francisco. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960751 Sun, 01 Nov 2009 00:00:00 +0100 2960751 http://www.medworm.com/index.php?rid=2960750&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705674%2Fabstract%3Frss%3Dyes According to Dr. Joel Ang, his vocation as a full-time family physician and his avocation as a violinist are irrevocably intertwined. In family medicine, he explained, “you have to think of a patient as someone who is multidimensional. In music, you do the same thing. You're trying to put things together, trying to work on very specific details of that piece.” (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960750 Sun, 01 Nov 2009 00:00:00 +0100 2960750 http://www.medworm.com/index.php?rid=2960749&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705662%2Fabstract%3Frss%3Dyes Dr. Eastern practices dermatology and dermatologic surgery in Belleville, N.J. To respond to this column, email Dr. Eastern at sknews@elsevier.com. The Centers for Medicare and Medicaid Services thinks it is overpaying you. That probably comes as no surprise, nor will the news that CMS has devised yet another scheme for taking back money that they have already paid to you. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960749 Sun, 01 Nov 2009 00:00:00 +0100 2960749 http://www.medworm.com/index.php?rid=2960748&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705650%2Fabstract%3Frss%3Dyes Allergan, the manufacturer of Botox (onabotulinumtoxinA), has sued the Food and Drug Administration, claiming that the agency's restrictions on off-label promotions are inhibiting the company's ability to “proactively share truthful and relevant information with the medical community,” according to a company statement. FDA's constraint that Allergan discuss off-label uses for Botox only in general terms violates the first amendment and hurts patients, Allergan claimed. To fully inform physicians, the company said it needs to describe dosing guidelines, patient selection criteria, and proper injection technique. “We believe that the inability to share such important information proactively with the medical community violates the First Amendment and potentially diminishes the quality o... Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960748 Sun, 01 Nov 2009 00:00:00 +0100 2960748 http://www.medworm.com/index.php?rid=2960747&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705649%2Fabstract%3Frss%3Dyes Heparin-induced skin lesions are fairly common among patients receiving heparin for treatment or prophylaxis, especially among women, and those who are overweight or who have taken the drug for more than 9 days, a new study has determined. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960747 Sun, 01 Nov 2009 00:00:00 +0100 2960747 http://www.medworm.com/index.php?rid=2960746&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705637%2Fabstract%3Frss%3Dyes BOCA RATON, FLA. — New guidelines for patient radiation dose management following neuroembolization procedures emphasize the need for physicians to inform and follow-up with patients about early and delayed adverse effects. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960746 Sun, 01 Nov 2009 00:00:00 +0100 2960746 http://www.medworm.com/index.php?rid=2960745&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705625%2Fabstract%3Frss%3Dyes SAN FRANCISCO — Insulin resistance may be present in patients with acanthosis nigricans, particularly if they are overweight or obese, and research increasingly supports a link between these conditions. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960745 Sun, 01 Nov 2009 00:00:00 +0100 2960745 http://www.medworm.com/index.php?rid=2960744&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705613%2Fabstract%3Frss%3Dyes PHILADELPHIA — Men and women with a history of migraine with aura were significantly more likely to die from cardiovascular disease than were those without headache. Women with nonmigraine headache were also significantly more likely to die from cardiovascular disease than were women without headache, but the hazard ratio was smaller, Dr. Larus S. Gudmundsson wrote in a poster presented at the International Headache Congress. The International Headache Society and the American Headache Society sponsored the congress. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960744 Sun, 01 Nov 2009 00:00:00 +0100 2960744 http://www.medworm.com/index.php?rid=2960743&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705601%2Fabstract%3Frss%3Dyes PHILADELPHIA — Migraine with or without aura is associated with a significant increase in the risk of cardiovascular disease, including stroke and heart attack. Numerous studies have hinted at the association between migraine with aura and cardiovascular events, Dr. Marcelo E. Bigal reported at the International Headache Congress. But the population-based study he performed with his colleague, Dr. Richard Lipton, was the first to examine the association in a large national sample in which migraine, with and without aura, had been officially diagnosed according to accepted standards. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960743 Sun, 01 Nov 2009 00:00:00 +0100 2960743 http://www.medworm.com/index.php?rid=2960742&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705595%2Fabstract%3Frss%3Dyes PHILADELPHIA — OnabotulinumtoxinA appears to be a safe, effective, and well-tolerated headache prophylactic for patients with chronic migraine. Two large randomized controlled trials showed that the toxin significantly reduced migraine frequency and improved headache-related disability over a 24- week period, Dr. David W. Dodick reported at the International Headache Congress. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960742 Sun, 01 Nov 2009 00:00:00 +0100 2960742 http://www.medworm.com/index.php?rid=2960741&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705583%2Fabstract%3Frss%3Dyes SAN FRANCISCO — Because children generally respond better to vitiligo interventions than adults, early recognition and treatment are crucial, Dr. Pearl E. Grimes said. “These patients need you. I strongly encourage you to be a little more aggressive when children with vitiligo come into your practice,” Dr. Grimes said at a seminar on women's and pediatric dermatology sponsored by Skin Disease Education Foundation (SDEF). (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960741 Sun, 01 Nov 2009 00:00:00 +0100 2960741 http://www.medworm.com/index.php?rid=2960740&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705571%2Fabstract%3Frss%3Dyes While most exanthems are self-limiting, some are not, making it important to establish a specific diagnosis, according to Dr. Anthony J. Mancini. “Parents want to go read up on these things, and they want to know how long it's going to take to go away,” Dr. Mancini said in an interview. “If you can characterize it … it's helpful for parents to know. At least they may have some answers. They know that it's going to take a while to resolve, and that saves you from follow-up phone calls and visits to the office when they're frantic because it's still there 4 weeks later.” (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960740 Sun, 01 Nov 2009 00:00:00 +0100 2960740 http://www.medworm.com/index.php?rid=2960739&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS003763370970556X%2Fabstract%3Frss%3Dyes PHILADELPHIA — A new dressing using a lipido-colloid contact layer reduced pain during dressing changes and improved quality of life for patients with epidermolysis bullosa. The 20 patients involved in the trial reported most of the dressing changes to be pain-free (91%). The remaining 9% of dressing changes were reported as mild to moderately painful, according to the results presented in a poster at the annual meeting of the Society for Pediatric Dermatology. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960739 Sun, 01 Nov 2009 00:00:00 +0100 2960739 http://www.medworm.com/index.php?rid=2960738&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705558%2Fabstract%3Frss%3Dyes PORTLAND, ORE. — If an infant presents with at least three hypopigmented macules, think tuberous sclerosis. Tuberous sclerosis is described as a triad of neurologic impairment, multisystem hamartomas, and skin findings (such as ash leaf macules and facial angiofibromas). The disease is of autosomal dominant inheritance, with an incidence of 1:6,000 to 1:10,000. Spontaneous mutation occurs in 50%-75% of cases. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960738 Sun, 01 Nov 2009 00:00:00 +0100 2960738 http://www.medworm.com/index.php?rid=2960737&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705546%2Fabstract%3Frss%3Dyes PHILADELPHIA — Infants with at least one typical site of nevus simplex involvement are likely to have involvement in less typical sites as well, according to a retrospective study of 28 infants. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960737 Sun, 01 Nov 2009 00:00:00 +0100 2960737 http://www.medworm.com/index.php?rid=2960736&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705534%2Fabstract%3Frss%3Dyes PHILADELPHIA — Isotretinoin appears to derive its effectiveness from increased production of the antimicrobial protein neutrophil-gelatinase associated lipocalin in the skin, reducing sebum levels, and in turn reducing levels of Propionibacterium acnes, according to new data. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960736 Sun, 01 Nov 2009 00:00:00 +0100 2960736 http://www.medworm.com/index.php?rid=2960735&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705522%2Fabstract%3Frss%3Dyes SAN FRANCISCO — Start simple and use a step-wise approach to treat children with atopic dermatitis, Dr. Sheila Fallon Friedlander recommended. “Atopic dermatitis matters so much because it can become infected, can impair physical and psychologic function, and has a tremendous effect on family quality of life,” Dr. Friedlander said at a seminar on women's and pediatric dermatology sponsored by Skin Disease Education Foundation. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960735 Sun, 01 Nov 2009 00:00:00 +0100 2960735 http://www.medworm.com/index.php?rid=2960734&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705510%2Fabstract%3Frss%3Dyes BUDAPEST, HUNGARY — Mild atopic dermatitis in patients with filaggrin mutations was associated with significantly greater skin barrier dysfunction than in patients with comparable wild-type atopic dermatitis in a comparative laboratory study. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960734 Sun, 01 Nov 2009 00:00:00 +0100 2960734 http://www.medworm.com/index.php?rid=2960733&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705509%2Fabstract%3Frss%3Dyes Budapest, Hungary — The calcineurin inhibitor pimecrolimus exerted more beneficial effects than betamethasone on the disrupted epidermal barrier of atopic dermatitis both structurally and immunologically, according to the results of a small randomized, double-blind study. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960733 Sun, 01 Nov 2009 00:00:00 +0100 2960733 http://www.medworm.com/index.php?rid=2960732&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705492%2Fabstract%3Frss%3Dyes PHOENIX — Investigators found significant decreases in thigh circumference following multiple treatments with a dual-wavelength laser system with mechanical manipulation, compared with untreated thighs, in a multicenter study. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960732 Sun, 01 Nov 2009 00:00:00 +0100 2960732 http://www.medworm.com/index.php?rid=2960731&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705480%2Fabstract%3Frss%3Dyes SAN FRANCISCO — Although changes to the aging face are often complex, knowing filler basics will help optimize results, Dr. Jason R. Michaels said. “When I approach patients, I try to keep it as basic as possible: who, what, where, why, and when?” Dr. Michaels said. “It is almost back to the grammar lessons we had as kids.” (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960731 Sun, 01 Nov 2009 00:00:00 +0100 2960731 http://www.medworm.com/index.php?rid=2960730&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705479%2Fabstract%3Frss%3Dyes PHOENIX — It may not be necessary to disclose all the potential risks of botulinum toxin that are listed in the black box warning on the label to cosmetic patients, said Dr. David J. Goldberg. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960730 Sun, 01 Nov 2009 00:00:00 +0100 2960730 http://www.medworm.com/index.php?rid=2960729&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705467%2Fabstract%3Frss%3Dyes Dr. Baumann is in private practice in Miami Beach. To respond to this column, or to suggest topics for future columns, write to Dr. Baumann at our editorial offices via e-mail at sknews@elsevier.com. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960729 Sun, 01 Nov 2009 00:00:00 +0100 2960729 http://www.medworm.com/index.php?rid=2960728&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705455%2Fabstract%3Frss%3Dyes BUDAPEST, HUNGARY — The oral probiotic Lactobacillus paracasei achieved substantial, clinically meaningful reductions in dandruff in a double-blind, placebo-controlled randomized trial. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960728 Sun, 01 Nov 2009 00:00:00 +0100 2960728 http://www.medworm.com/index.php?rid=2960727&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705443%2Fabstract%3Frss%3Dyes New genetic research is yielding some important clues into the puzzling condition of alopecia areata, Dr. Maria Hordinsky reported at the women's and pediatric dermatology seminar sponsored by Skin Disease Education Foundation (SDEF). (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960727 Sun, 01 Nov 2009 00:00:00 +0100 2960727 http://www.medworm.com/index.php?rid=2960726&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705431%2Fabstract%3Frss%3Dyes The way Dr. Joseph Kim sees it, influenza vaccine development needs an extreme makeover. “Every year, three flu strains are selected by the flu experts around the world, which determines which strains the vaccine makers should make,” Dr. Kim, president and CEO of San Diego–based Inovio Biomedical Corp., said in an interview. “They can guess right, or they can guess wrong, but every year, you have to change the vaccine.” He wants to change that paradigm. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960726 Sun, 01 Nov 2009 00:00:00 +0100 2960726 http://www.medworm.com/index.php?rid=2960725&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS003763370970542X%2Fabstract%3Frss%3Dyes SAN FRANCISCO — A short course of therapy with torezolid phosphate cured virtually all patients with Staphylococcus aureus—based severe complicated skin and skin structure infections in a randomized, double-blind, phase II study. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960725 Sun, 01 Nov 2009 00:00:00 +0100 2960725 http://www.medworm.com/index.php?rid=2960724&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705418%2Fabstract%3Frss%3Dyes The Food and Drug Administration has approved the drug Gardasil for boys and men aged 9–26 years, and Cervarix for girls and women aged 10–25 years. Gardasil was approved for preventing genital warts associated with the human papillomavirus (HPV), according to a statement from the drug's manufacturer, Merck & Co. An FDA press officer confirmed the approval. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960724 Sun, 01 Nov 2009 00:00:00 +0100 2960724 http://www.medworm.com/index.php?rid=2960723&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705406%2Fabstract%3Frss%3Dyes San Francisco — A newly approved cream containing 5% acyclovir and 1% hydrocortisone prevented ulcerated lesions in patients with recurrent herpes simplex labialis, compared with both topical acyclovir and placebo, a large multicenter study showed. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960723 Sun, 01 Nov 2009 00:00:00 +0100 2960723 http://www.medworm.com/index.php?rid=2960722&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS003763370970539X%2Fabstract%3Frss%3Dyes Vaccination for the pandemic influenza A(H1N1) virus remains critical, because it is medicine's best tool for preventing or moderating infection, officials with the Centers for Disease Control and Prevention continued to stress last month. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960722 Sun, 01 Nov 2009 00:00:00 +0100 2960722 http://www.medworm.com/index.php?rid=2960721&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705388%2Fabstract%3Frss%3Dyes The American Medical Association has created a new Current Procedural Terminology code (90470) and revised an existing code (90663) for use with H1N1 vaccinations, according to a statement from the association. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960721 Sun, 01 Nov 2009 00:00:00 +0100 2960721 http://www.medworm.com/index.php?rid=2960720&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705376%2Fabstract%3Frss%3Dyes Despite clinical evidence suggesting that children are at higher risk for pandemic influenza A(H1N1) complications, only 40% of parents surveyed said they plan to have their children vaccinated against that strain of the flu. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960720 Sun, 01 Nov 2009 00:00:00 +0100 2960720 http://www.medworm.com/index.php?rid=2960719&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705364%2Fabstract%3Frss%3Dyes Budapest, Hungary — Switching renal transplant recipients from azathioprine to mycophenolate mofetil for long-term immunosuppression significantly reduced UVA photosensitivity in a crossover study. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960719 Sun, 01 Nov 2009 00:00:00 +0100 2960719 http://www.medworm.com/index.php?rid=2960718&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705352%2Fabstract%3Frss%3Dyes Berlin — An investigational agent that targets the BRAF mutation and is present in at least half of melanoma patients has shown impressive results in a second phase I trial. Response rates with the oral agent PLX4032 reached an unprecedented 70% in metastatic melanoma, signaling a fundamental shift in the way this deadly disease will be treated. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960718 Sun, 01 Nov 2009 00:00:00 +0100 2960718 http://www.medworm.com/index.php?rid=2960717&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705340%2Fabstract%3Frss%3Dyes I oppose board certification in procedural dermatology. Even the title of the fellowship, procedural dermatology, is perplexing. Does this make all of the other dermatologists nonprocedural? The practice of dermatology is, by definition, procedural (“Certification Plan for Procedural Derm Postponed,” September 2009, p. 1). (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960717 Sun, 01 Nov 2009 00:00:00 +0100 2960717 http://www.medworm.com/index.php?rid=2960716&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705339%2Fabstract%3Frss%3Dyes Dr. Rockoff practices dermatology in Brookline, Mass. To respond to this column, e-mail Dr. Rockoff at sknews@elsevier.com. I'm old enough to remember the actor Robert Young in “Father Knows Best.” Because his later hit TV series “Marcus Welby, M.D.” aired when I was in medical school and residency, I never saw a single episode, but his image as the kindly general practitioner who knew everybody in town seeped into my consciousness. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960716 Sun, 01 Nov 2009 00:00:00 +0100 2960716 http://www.medworm.com/index.php?rid=2960715&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705327%2Fabstract%3Frss%3Dyes Dr. Glogau is clinical professor of dermatology at the University of California, San Francisco. He is a paid consultant and clinical investigator for Allergan, Revance Therapeutics, and Medicis. He has also served as a clinical investigator for Contura. To respond to this column, e-mail Dr. Glogau at sknews@elsevier.com. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960715 Sun, 01 Nov 2009 00:00:00 +0100 2960715 http://www.medworm.com/index.php?rid=2960714&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705315%2Fabstract%3Frss%3Dyes BERLIN — Impaired sexual function is extremely common in the setting of moderate to severe psoriasis, and ustekinumab therapy reduces these problems by 10-fold. That's a key quality of life finding from the ongoing randomized double-blind phase III PHOENIX-1 and −2 clinical trials of this human monoclonal antibody directed against the proinflammatory cytokines interkeukin-12 and −23, Dr. Lyn Guenther reported at the annual congress of the European Academy of Dermatology and Venereology. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960714 Sun, 01 Nov 2009 00:00:00 +0100 2960714 http://www.medworm.com/index.php?rid=2960713&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705303%2Fabstract%3Frss%3Dyes BERLIN — Omalizumab proved effective and safe in patients with moderate to severe chronic urticaria refractory to antihistamines in a double-blind, placebo-controlled, multicenter trial. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960713 Sun, 01 Nov 2009 00:00:00 +0100 2960713 http://www.medworm.com/index.php?rid=2960712&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705297%2Fabstract%3Frss%3Dyes BUDAPEST, HUNGARY — Topical or oral antiangiogenic therapy may offer a novel avenue of treatment in inflammatory skin diseases such as psoriasis and rosacea. In what he described as the first proof-of-concept study to show that blocking the vascular endothelial growth factor (VEGF) receptor may provide an entirely new approach to treating chronic inflammatory skin conditions, Dr. Michael Detmar presented highlights of his research during a satellite symposium held in conjunction with the annual meeting of the European Society for Dermatological Research. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960712 Sun, 01 Nov 2009 00:00:00 +0100 2960712 http://www.medworm.com/index.php?rid=2960711&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705285%2Fabstract%3Frss%3Dyes The Food and Drug Administration's approval of ustekinumab for moderate to severe plaque psoriasis—the first interleukin-12 and −23 antagonist to be approved in the United States—is accompanied by requirements for a risk management plan and postmarketing studies that address uncertainties about the long-term safety of the biologic drug. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960711 Sun, 01 Nov 2009 00:00:00 +0100 2960711 http://www.medworm.com/index.php?rid=2960710&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705273%2Fabstract%3Frss%3Dyes BUDAPEST, HUNGARY — More than 100 psoriasis patients treated with adalimumab, etanercept, or infliximab experienced marked clinical improvement for every patient who developed a serious adverse event, according to a risk-benefit analysis of the major randomized trials of the tumor necrosis factor antagonists. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960710 Sun, 01 Nov 2009 00:00:00 +0100 2960710 http://www.medworm.com/index.php?rid=2960709&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705261%2Fabstract%3Frss%3Dyes BETHESDA, MD. — A Food and Drug Administration advisory panel cast mixed votes on whether data on an injectable product derived from autologous fibroblast cells had demonstrated that it was safe and effective for treating moderate to severe nasolabial fold wrinkles in adults, the indication for which it is under review for approval. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960709 Sun, 01 Nov 2009 00:00:00 +0100 2960709 http://www.medworm.com/index.php?rid=2960708&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS003763370970525X%2Fabstract%3Frss%3Dyes BUDAPEST, HUNGARY — When the off-label treatment of severe pemphigus vulgaris using anti–tumor necrosis factor–alpha agents is prohibitively expensive or medically contraindicated, consider treating with the TNF-alpha–lowering combination of sulfasalazine plus pentoxifylline, which proved to be safe and effective in a double-blind, randomized trial. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960708 Sun, 01 Nov 2009 00:00:00 +0100 2960708 http://www.medworm.com/index.php?rid=2960707&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705248%2Fabstract%3Frss%3Dyes BUDAPEST, HUNGARY — New European guidelines on high-dose intravenous immunoglobulin therapy in autoimmune dermatologic diseases restrict the first-line indications to toxic epidermal necrolysis, Kawasaki disease, and life-threatening, rapidly progressive cases of dermatomyositis. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960707 Sun, 01 Nov 2009 00:00:00 +0100 2960707 http://www.medworm.com/index.php?rid=2960706&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705236%2Fabstract%3Frss%3Dyes WASHINGTON — After months of internal debate, the Senate Finance Committee passed a health care reform bill aimed at expanding health coverage and making health insurance more affordable. The 14-9 vote in favor of the bill was split largely along party lines, with Sen. Olympia Snowe of Maine the lone Republican to cross over and vote for the bill along with 13 Democratic colleagues. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960706 Sun, 01 Nov 2009 00:00:00 +0100 2960706 http://www.medworm.com/index.php?rid=2960705&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705224%2Fabstract%3Frss%3Dyes The 2010 edition of the Centers for Disease Control and Prevention's “Yellow Book” on health information for international travelers is now available on-line (www.cdc.gov/travel) and in hard copy. Published by Elsevier, the book, which always has a yellow cover, includes information on topics ranging from jet lag, cruise ship travel, and international adoptions to respiratory conditions, drug-vaccine interactions, and persistent travelers' diarrhea. Some topics such as medical tourism are appearing for the first time. More information can be obtained from www.us.elsevierhealth.com. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960705 Sun, 01 Nov 2009 00:00:00 +0100 2960705 http://www.medworm.com/index.php?rid=2960704&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705212%2Fabstract%3Frss%3Dyes PHOENIX — California Governor Arnold Schwarzenegger signed a bill into law that raises public awareness about the risks of cosmetic surgery and targets the aggressive marketing of services that make the risks “seem almost nonexistent,” California State Assemblywoman Wilmer Amina Carter said. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960704 Sun, 01 Nov 2009 00:00:00 +0100 2960704 http://www.medworm.com/index.php?rid=2960703&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705200%2Fabstract%3Frss%3Dyes BERLIN — Selective inhibition of the proinflammatory cytokine interleukin-17A using a novel fully human monoclonal antibody showed considerable early promise for treatment of psoriasis in a phase II double-blind randomized trial. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960703 Sun, 01 Nov 2009 00:00:00 +0100 2960703 http://www.medworm.com/index.php?rid=2960702&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705194%2Fabstract%3Frss%3Dyes GAITHERSBURG, MD. — Peginterferon alfa-2b has a favorable risk-benefit ratio as an adjuvant treatment for stage III melanoma, a Food and Drug Administration advisory panel said (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960702 Sun, 01 Nov 2009 00:00:00 +0100 2960702 http://www.medworm.com/index.php?rid=2960701&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705182%2Fabstract%3Frss%3Dyes (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960701 Sun, 01 Nov 2009 00:00:00 +0100 2960701 http://www.medworm.com/index.php?rid=2960700&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705170%2Fabstract%3Frss%3Dyes A 30-year-old male presented with a 2-year history of recurrent oral ulcers with individual lesions lasting 5 days to 2 weeks. He had recently developed multiple oral ulcers lasting more than 2 weeks bilaterally on the tongue, gum line, and buccal mucosa. What's your diagnosis? See Case of the Month, page 47. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960700 Sun, 01 Nov 2009 00:00:00 +0100 2960700 http://www.medworm.com/index.php?rid=2960699&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705169%2Fabstract%3Frss%3Dyes BERLIN — Look for a big jump in the number of melanoma patients diagnosed with stage III disease beginning early next year, when the new American Joint Committee on Cancer classification system takes effect. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960699 Sun, 01 Nov 2009 00:00:00 +0100 2960699 http://www.medworm.com/index.php?rid=2960698&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705157%2Fabstract%3Frss%3Dyes BERLIN — Lichen planus, like psoriasis, appears to be intrinsically associated with an increased prevalence of dyslipidemia, according to a large Israeli case-control study. “Of course, this is a pioneering study and I'd like to see it repeated in other databases. Nevertheless, we suggest that patients with lichen planus might be candidates for dyslipidemia screening,” Dr. Arnon D. Cohen said at the annual congress of the European Academy of Dermatology and Venereology. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2960698 Sun, 01 Nov 2009 00:00:00 +0100 2960698 http://www.medworm.com/index.php?rid=2867103&cid=s_38668_12_f&fid=38668&url=http%3A%2F%2Fwww.skinandallergynews.com%2Farticle%2FPIIS0037633709705145%2Fabstract%3Frss%3Dyes This case of leukemia cutis due to aggressive natural killer cell leukemia is uncommon, and perhaps even unique. Leukemia cutis seldom occurs in children, and is seen in only 6%-9% of children with leukemia. There have been only a few reports of aggressive natural killer (NK) cell leukemia presenting in childhood. This may be the first case of bullous leukemia cutis and aggressive NK cell leukemia in a child, according to Dr. Harper N. Price. The girl also tested negative for Epstein-Barr virus (EBV), which commonly is present in aggressive NK cell leukemia. She appears to be the first child to be reported with EBV-negative aggressive NK cell leukemia. (Source: Skin and Allergy News) Skin and Allergy News journals http://www.medworm.com/rss/comments.php?id=2867103 Wed, 30 Sep 2009 23:00:00 +0100 2867103